The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5040245 6069546 F 5040245-3 20060316 20051118 20060630 EXP PHEH2005US12835 NOVARTIS PHARMACEUTICALS CORP. 34 YR F Y 20060630 UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5040245 1007430374 C METHYLDOPA 1 ORAL UNK, TID
5040245 1007430375 C PRENATAL VITAMINS 2
5040245 1007430376 PS LOTREL 1 ORAL 020364
5040245 1007430377 SS LOTREL 1 ORAL 10/20MG 020364

Indications of drugs used

Event ID DRUG SEQ INDI PT
5040245 1007430376 HYPERTENSION

Outcome of event

Event ID OUTC COD
5040245 OT

Reactions reported

Event ID PT
5040245 DRUG EXPOSURE DURING PREGNANCY
5040245 INDUCED LABOUR
5040245 PRE-ECLAMPSIA
5040245 PREGNANCY INDUCED HYPERTENSION
5040245 PREMATURE LABOUR

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5040245 1007430374 20050817
5040245 1007430377 20050801